(Q42563157)

2 November 2017

Taking thalidomide out of rehab (English)

1 reference

2 November 2017

0 references

1

Rosemary J Akhurst

1 reference

PMC publication ID

2917634

2 November 2017

language of work or name

English

0 references

publication date

1 April 2010

1 reference

2 November 2017

1 reference

2 November 2017

16

1 reference

2 November 2017

4

1 reference

2 November 2017

370-372

1 reference

Thalidomide stimulates vessel maturation and reduces epistaxis in individuals with hereditary hemorrhagic telangiectasia

2 November 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2917634

A pharmacogenetic study of docetaxel and thalidomide in patients with castration-resistant prostate cancer using the DMET genotyping platform.

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2917634

Thalidomide-induced limb defects: resolving a 50-year-old puzzle

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2917634

Bevacizumab reverses need for liver transplantation in hereditary hemorrhagic telangiectasia.

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2917634

Potential role of modifier genes influencing transforming growth factor-beta1 levels in the development of vascular defects in endoglin heterozygous mice with hereditary hemorrhagic telangiectasia.

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2917634

Thalidomide is an inhibitor of angiogenesis

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2917634

Agents that increase cAMP accumulation block endothelial c-sis induction by thrombin and transforming growth factor-beta

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2917634

Thalidomide down-regulates the expression of VEGF and bFGF in cisplatin-resistant human lung carcinoma cells.

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2917634

Genetic heterogeneity of angiogenesis in mice.

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2917634

Genetic modifiers interact with maternal determinants in vascular development of Tgfb1(-/-) mice

16 August 2018

1 reference

12 December 2020

Gap junction communication mediates transforming growth factor-beta activation and endothelial-induced mural cell differentiation

1 reference

12 December 2020

Genetic loci that control vascular endothelial growth factor-induced angiogenesis

1 reference

12 December 2020

Dramatic improvement in hereditary hemorrhagic telangiectasia after treatment with the vascular endothelial growth factor (VEGF) antagonist bevacizumab

1 reference

12 December 2020

Identifiers

DOI

10.1038/NM0410-370

1 reference

2 November 2017

1 reference

PMC publication ID

2917634

2 November 2017

PubMed publication ID

20376039

1 reference

PMC publication ID

2917634